RenovaCare Provides Clinical and Corporate Update

Scottsdale, AZ – March 09, 2022 – RenovaCare, Inc. (Symbol: RCAR;, developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced that following the review of its research and corporate activities, the Company is taking steps to streamline its clinical, research and development, and administrative operations in order to reduce costs.